STAT3 and hepatocellular carcinoma: Treatment with DHCT (IC20) for 48 h strongly reduced the migration (Figure 4(a)) and invasion (Figure 4(b)) capacity of cells, showing that JAK/STAT3 inhibitor effectively reduced the motility and invasiveness of nicotine stimulated HCC cells when compared with the nontreated control counterpart.